Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Tag: #Global Trends

Next-Generation Vaccinology & In Silico mRNA Platforms: GSK Advances Dual-Antigen (HA + NA) mRNA Seasonal Influenza Candidate to Phase 3 Trials – Challenging Moderna Following Superior Immune Responses in Young and Older Adult Cohorts

03/09/2026 Published by Pharma Biz

Key Development On September 1, 2026, British biopharmaceutical leader GSK plc (LSE/NYSE: GSK) announced the advancement of its investigational mRNA-based... Read more

Category: Uncategorized

Tags: #Global Trends

Targeted Thoracic Oncology: AstraZeneca and Hutchmed Report Statistically Significant Progression-Free Survival Benefit in Phase 3 Trial Evaluating First-Line Tagrisso® (Osimertinib) Plus Orpathys® (Savolitinib) in EGFRm / MET+ Advanced NSCLC

03/09/2026 Published by Pharma Biz

Key Development On September 1, 2026, biopharmaceutical multinational AstraZeneca (LSE: AZN / Nasdaq: AZN) and its partner Hutchmed (China) Limited... Read more

Category: Uncategorized

Tags: #Global Trends

Pediatric Nutrition Litigation & Product Liability Defense: U.S. Federal Bellwether Jury Delivers Complete Defense Verdict for Mead Johnson (Reckitt) Over Enfamil – Rejecting Causation Claims in Preterm Necrotizing Enterocolitis (NEC)

03/09/2026 Published by Pharma Biz

Key Development On September 1, 2026, a federal jury in Illinois returned a complete defense verdict in favor of Mead... Read more

Category: Uncategorized

Tags: #Global Trends

Hematologic Oncology & Next-Gen Multispecifics: Roche Inks Potential $1.53 Billion Global Licensing Agreement for Simcere Zaiming’s Preclinical Trispecific T-Cell Engager SIM0660 (CD79a × CD19 × CD3) Targeting Relapsed B-Cell Malignancies and Autoimmune Disorders

03/09/2026 Published by Pharma Biz

Key Development On September 1, 2026, Swiss healthcare conglomerate Roche Holding AG (SIX: RO / ROPC) entered into an exclusive... Read more

Category: Uncategorized

Tags: #Global Trends

Agricultural Life Sciences & Global Agrifood Resilience: Bayer Launches First 2 of 10 Projected €500M+ Blockbusters – Advancing Plenexos® Insecticide and Preceon® Smart Corn System Alongside €400M in Operational Cost Savings

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, during an institutional investor symposium convened in Iowa, German life sciences conglomerate Bayer AG... Read more

Category: Uncategorized

Tags: #Global Trends

AI-Driven Drug Discovery & Computational Oncology: Boehringer Ingelheim Licenses Owkin’s ‘K Pro’ AI Engine and Multimodal Biological Datasets to Accelerate Target Identification in Cancer and Immunology

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, biomedical artificial intelligence innovator Owkin, Inc. entered into a strategic licensing and research partnership... Read more

Category: Uncategorized

Tags: #Global Trends

Biopharmaceutical Manufacturing Recovery & Incretin Strategy: Aspen Pharmacare Projects FY27 Normalized EBITDA of at Least 9 Billion Rand ($561 Million) – Accelerating Generic Semaglutide Expansion Across Emerging Markets Alongside Exclusive Mounjaro Commercialization

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, South Africa-based pharmaceutical leader Aspen Pharmacare Holdings Ltd. (JSE: APN) issued financial guidance for... Read more

Category: Uncategorized

Tags: #Global Trends

Pediatric Nutrition & Biomanufacturing Infrastructure: Nestlé Commits $393 Million (2 Billion Reais) to Brazil Nutrition & Health Division – Constructing New Infant Formula Plant in Minas Gerais to Localize Supply and Anchor Latin American Exports

03/09/2026 Published by Pharma Biz

Key Development On September 3, 2026, global nutrition and health science leader Nestlé S.A. (SIX: NESN) announced a 2 billion... Read more

Category: Uncategorized

Tags: #Global Trends

Tobacco Regulatory Litigation & Administrative Law: Altria Sues US FDA in Federal Court Demanding Complete Overhaul of Premarket Tobacco Application (PMTA) Framework – Citing Statutory 180-Day Deadlines and Market Distortions Across the $22 Billion Sector

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, Altria Group, Inc. (NYSE: MO)—the manufacturer of Marlboro cigarettes in the United States—alongside two... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Page 1 Page 2 … Page 92 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Online Members

Recent Comments

GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication

HEALTHCARE INSIGHTS

All rights reserved